Evidence map›Paper›PMID 33359552›Full record

ArticleAmerican journal of infection control2021

Implementing daily chlorhexidine gluconate (CHG) bathing in VA settings: The human factors engineering to prevent resistant organisms (HERO) project.

Mary Jo Knobloch, Jackson S Musuuza, Linda McKinley, Michele L Zimbric, Kelsey Baubie, Ann Schoofs Hundt, Pascale Carayon, Mary Hagle, Christopher D Pfeiffer, Marinella D Galea and 2 more

Open access · greenAbstract read
In one paragraph

Article in American journal of infection control, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Exploring facilitators and barriers to daily chlorhexidine gluconate bathing in adult patients undergoing hematopoietic stem cell transplantation.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Mary Jo KnoblochDepartment of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI; William S. Middleton Memorial Veterans Hospital, Madison, WI. Electronic address: Maryjo.Knobloch@va.gov.
Jackson S MusuuzaDepartment of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI; William S. Middleton Memorial Veterans Hospital, Madison, WI.
Linda McKinleyDepartment of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI; William S. Middleton Memorial Veterans Hospital, Madison, WI.
Michele L ZimbricDepartment of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI.
Kelsey BaubieWilliam S. Middleton Memorial Veterans Hospital, Madison, WI.
Ann Schoofs HundtCenter for Quality and Productivity Improvement, University of Wisconsin-Madison, Madison, WI; Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI.
Pascale CarayonCenter for Quality and Productivity Improvement, University of Wisconsin-Madison, Madison, WI; Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI.
Mary HagleClement J. Zablocki VA Medical Center, Milwaukee, WI.
Christopher D PfeifferVA Portland HealthCare System, Portland, OR; Department of Medicine, Oregon Health and Science University, Portland, OR.
Marinella D GaleaJames J Peters Medical Center, Bronx, NY; Icahn School of Medicine at Mount Sinai, Department of Rehabilitation and Human Performance, New York, NY; New York Presbyterian Hospital, Columbia University School of Medicine, Department of Medicine, New York, NY.
Christopher J CrnichDepartment of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI; William S. Middleton Memorial Veterans Hospital, Madison, WI.
Nasia SafdarDepartment of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI; William S. Middleton Memorial Veterans Hospital, Madison, WI.
University of Wisconsin–Madison · USWilliam S. Middleton Memorial Veterans Hospital · USMilwaukee VA Medical Center · USNewYork–Presbyterian Hospital · USOregon Health & Science University · US

Funding

HSRD VA I50 HX001975
6 · The paper itself

Abstract

backgroundDaily use of chlorhexidine gluconate (CHG) has been shown to reduce risk of healthcare-associated infections. We aimed to assess moving CHG bathing into routine practice using a human factors approach. We evaluated implementation in non-intensive care unit (ICU) settings in the Veterans Health Administration.

methodsOur multiple case study approach included non-ICU units from 4 Veterans Health Administration settings. Guided by the Systems Engineering Initiative for Patient Safety, we conducted focus groups and interviews to capture barriers and facilitators to daily CHG bathing. We measured compliance using observations and skin CHG concentrations.

resultsBarriers to daily CHG include time, concern of increasing antibiotic resistance, workflow and product concerns. Facilitators include engagement of champions and unit shared responsibility. We found shortfalls in patient education, hand hygiene and CHG use on tubes and drains. CHG skin concentration levels were highest among patients from spinal cord injury units. These units applied antiseptic using 2% CHG impregnated wipes vs 4% CHG solution/soap. DISCUSSION: Non-ICUs implementing CHG bathing must consider human factors and work system barriers to ensure uptake and sustained practice change.

conclusionsWell-planned rollouts and a unit culture promoting shared responsibility are key to compliance with daily CHG bathing. Successful implementation requires attention to staff education and measurement of compliance.

Indexed as

Anti-Infective Agents, LocalCross InfectionBathsChlorhexidineErgonomicsHumansIntensive Care UnitsAnti-Infective Agents, LocalChlorhexidinechlorhexidine gluconateCase studyChampionsContextual factorsOrganizational cultureQuality improvementSystems engineering

Identifiers

PMID33359552
PMCPMC9670156
OpenAlexW3118213573

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.